Home » Topics » Conferences

Conferences
RSS

Roche describes TK inhibitors for recurrent HSV infection

May 5, 1997

Trimeris prepares potent peptide inhibitors of viral fusion

April 30, 1997

Potent inhibitors of HIV-1 and other enveloped viruses reported

April 30, 1997

Dendrimer polyanions with activity against RSV

April 30, 1997

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.